At the news
? BULLISHIMPACT 4/10 CLUSTER filed Nov 12, 2026 at 18:00 ET
Multiple Larimar Therapeutics insiders, including the CEO, CFO, President/COO, and directors, made open-market purchases totaling approximately $382K in the week following the company's BLA submission for nomlabofusp. The cluster represents about 0.13% of market cap, a modest but notable signal of insider confidence after a major regulatory milestone.
- Seven insiders purchased shares in a 7-day window (Nov 11-12, 2026)
- Total open-market purchases: ~$382K across all seven insiders
- CEO Carole Ben-Maimon purchased $50K worth of shares
- CFO Michael Celano purchased $50K worth of shares
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access